About this page
Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.
How to read it
- Form 4
- The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
- Buy (P) and Sell (S)
- Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
- Value
- Shares times price, as reported on the filing.
- 10b5-1
- A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
- Late filing
- A Form 4 filed more than two business days after the trade.
- Vs. S&P 500
- How the stock did after the trade minus how the overall market did in the same weeks.
A real example
In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.
Explain it like I'm 13
If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.
Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.
Edwards Lifesciences Corp (EW): Insider Trades and Fund Holdings
In the past 12 months, Edwards Lifesciences Corp insiders reported no open-market purchases and 13 sales worth $4.70M; 6 of the sales were reported as made under a 10b5-1 trading plan.
Timeline: news and trades
Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.
- Oct 8, 2026Insider saleCVP, TAVR Daniel J. Lippis sold $53,017 under a 10b5-1 plan
- Sep 11, 2026Insider saleCVP, TAVR Daniel J. Lippis sold $54,169 under a 10b5-1 plan
- Aug 31, 2026Insider saleSVP Andrew M. Dahl sold $49,534 (3 days after: executive or director change)
- Aug 31, 2026Planned saleDahl Andrew M. (officer) filed notice to sell about $49,534 around Aug 31, 2026
- Aug 28, 2026NewsCompany reported: Executive or director change
- Aug 28, 2026Insider saleCVP, EMEACLA Annette Bruls sold $237,907 (0 days after: executive or director change)
- Aug 28, 2026Planned saleBruls Annette (officer) filed notice to sell about $237,907 around Aug 28, 2026
- Aug 26, 2026Insider saleCVP, TMTT, Surgical & IHFM Daveen Chopra sold $2.9 million
- Aug 26, 2026Insider saleCVP, JAPAC Wayne Markowitz sold $113,417
- Aug 26, 2026Planned saleChopra Daveen (officer) filed notice to sell about $2.9 million around Aug 26, 2026
- Aug 26, 2026Planned saleMarkowitz Wayne (officer) filed notice to sell about $113,417 around Aug 26, 2026
- Aug 11, 2026Insider saleCVP, TAVR Daniel J. Lippis sold $56,967 under a 10b5-1 plan
- Aug 11, 2026Planned saleLippis Daniel J. (officer) filed notice to sell about $170,900 around Aug 11, 2026
- Jul 30, 2026Insider saleCVP, JAPAC Wayne Markowitz sold $12,588
- Jul 30, 2026Planned saleUllem Scott B. (former affiliate) filed notice to sell about $4.6 million around Jul 30, 2026
- Jul 30, 2026Planned saleMarkowitz Wayne (officer) filed notice to sell about $12,588 around Jul 30, 2026
- Jul 28, 2026Insider saleCVP, JAPAC Wayne Markowitz sold $818,958
- Jul 28, 2026Planned saleMarkowitz Wayne (officer) filed notice to sell about $818,958 around Jul 28, 2026
- Jul 27, 2026Insider saleCEO Bernard J. Zovighian sold $245,134
- Jul 10, 2026Insider saleCVP, TAVR Daniel J. Lippis sold $56,762 under a 10b5-1 plan
- Jun 30, 2026Insider saleCVP, TAVR Daniel J. Lippis sold $56,577 under a 10b5-1 plan
- Jun 30, 2026FundBridgewater Associates added 60% in Q2 2026 (13F filed Aug 14, 2026)
- Jun 30, 2026FundViking Global Investors sold out in Q2 2026 (13F filed Aug 14, 2026)
- Jun 30, 2026FundRenaissance Technologies cut 28% in Q2 2026 (13F filed Aug 13, 2026)
- Jun 17, 2026Insider saleCEO Bernard J. Zovighian sold $45,982 under a 10b5-1 plan
- Nov 19, 2025CongressRep. Josh Gottheimer sell $1K–$15K (joint)
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 8, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 8 | Daniel J. LippisCVP, TAVR | ▼ SELL10b5-1 | $53K |
| Sep 11 | Daniel J. LippisCVP, TAVR | ▼ SELL10b5-1 | $54K |
| Aug 31 | Andrew M. DahlSVP | ▼ SELL | $50K |
| Aug 28 | Annette BrulsCVP, EMEACLA | ▼ SELL | $238K |
| Aug 26 | Daveen ChopraCVP, TMTT, Surgical & IHFM | ▼ SELL | $2.89M |
| Aug 26 | Wayne MarkowitzCVP, JAPAC | ▼ SELL | $113K |
| Aug 11 | Daniel J. LippisCVP, TAVR | ▼ SELL10b5-1 | $57K |
| Jul 30 | Wayne MarkowitzCVP, JAPAC | ▼ SELL | $13K |
| Jul 28 | Wayne MarkowitzCVP, JAPAC | ▼ SELL | $819K |
| Jul 27 | Bernard J. ZovighianCEO | ▼ SELL | $245K |
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Daniel J. Lippis | CVP, TAVR | 0 | $0 | 5 | $277K |
| Andrew M. Dahl | SVP | 0 | $0 | 1 | $50K |
| Annette Bruls | CVP, EMEACLA | 0 | $0 | 1 | $238K |
| Daveen Chopra | CVP, TMTT, Surgical & IHFM | 0 | $0 | 1 | $2.89M |
| Wayne Markowitz | CVP, JAPAC | 0 | $0 | 3 | $945K |
| Bernard J. Zovighian | CEO | 0 | $0 | 2 | $291K |
Trades by members of Congress
Reported under the STOCK Act. Amounts are ranges from the form. All Congress trades →
| Filed | Member | Type | Amount |
|---|---|---|---|
| Dec 29 |  Rep. Josh GottheimerD-NJ-5 | ▼ SELL | $1K–$15K |
Buybacks and executive pay
Edwards Lifesciences Corp spent $893.4 million buying back its own shares in 2025.
From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.
A All 13 insider trades reported on time. How it is graded
Tracked funds that report EW
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Bridgewater Associates | 275,279 | $24.9M | ▲ +60.1% |
| Renaissance Technologies | 21,000 | $1.90M | ▼ −27.6% |
| Viking Global Investors | 0 | $0 | ▼ Sold out |
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →